Clinical trial
Randomized Control Trial of Home-based Hepatitis C Self-testing in Key Populations in Georgia
NCT04961723 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Control Trial of Home-based Hepatitis C Self-testing in Key Populations in Georgia
- Lead sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 10, 2021
- Completion date
- August 30, 2022
- Enrollment
- 1,250 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
diagnostic self evaluation, hepatitis c